Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more

Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more
BMO sees BMRN, LEGN, SLN as attractive M&A targets
Cramer's lightning round: I would hold onto Biomarin Pharmaceutical
Watch BioMarin Pharmaceutical after Turning Point sale to Bristol Myers - analyst
#earnings after the close https://t.co/lObOE0dgsr $F $TDOC $TWLO $NOW $EBAY $ALGN $UPWK $LC $SU $AR $XLNX $NLY $IRBT $KLAC $SNBR $MKSI $URI $CCS $YUMC $EW $SIMO $VICI $BMRN $CTSH $BOOT $ORLY $NTGR $AEM $UCTT $AFL $MXL $ALSN $RJF $EQT $NOVA $NOA $TROX $SAVE $CACI $EXR $ALGT https://t.co/PFBn7b2UNd
10.83BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09061G1013
CUSIP
09061G101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
150.68
PEG Ratio
0.33
Book Value
32.66
Dividend Share
-
Dividend Yield
-
Earnings Share
0.37
Wall Street Target Price
91.56
EPS Estimate Current Year
3.51
EPS Estimate Next Year
6.39
EPS Estimate Current Quarter
0.9542
EPS Estimate Next Quarter
1.4903
Most Recent Quarter
-
Revenue TTM
3,406,614,016
Gross Profit TTM
1,736,295,040
EBITDA
645,318,976
Profit Margin
2.14%
Return On Assets TTM
3.26%
Return On Equity TTM
1.18%
Revenue Per Share TTM
17.692
Qtly Revenue Growth YOY
19.90%
Diluted Eps TTM
0.37
Qtly Earnings Growth YOY
-81.30%
Trailing PE
150.68
Forward PE
8
Price Sales TTM
3.1679
Price Book MRQ
1.7132
Enterprise Value Revenue
4
Enterprise Value EBITDA
36
206.75
4.58%305.59
4.16%882.35
1.82%816.10
1.09%520.00
0.54%790.15
0.00%136.90
0.00%366.06
-1.28%34.16
-1.27%151.18
-0.48%